UnitedHealth Just Raised Guidance for the Third Time This Year. Where Will the Stock Be in 3 Years?

UnitedHealth Group has raised its 2026 earnings guidance for the third time this year, with adjusted EPS now targeted at $20.50, up from $17.75 in January. The company's turnaround is gaining momentum, driven by operational improvements in Optum Health and better medical cost management. Analysts project the stock could reach between $444 and $672 by 2029 based on 13-16% annual earnings growth, though regulatory scrutiny and rising medical costs remain risks.